1Tamargo J. Drug-induced torsade de pointes: from molecular biology to bedside[J]. Jnp J Pharmacol,2000,83(1):1-6. 被引量：1
2Calderone V, Cavero I. Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval[J]. Minerva Med, 2002,93 (3) : 181-197. 被引量：1
3Iannini PB. Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval[J]. Expert Opin Drug Saf, 2002,1 (2) : 121-128. 被引量：1
4Zitron E, Kiesecker C, Scholz E, et al. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone[J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2004,370(2):146-156. 被引量：1
5Lewis BK, Jean PV. Safety pharmacology and risk assessment[J]. Science Fundamental & Clinical Pharmacology, 2002, 16:175-182. 被引量：1
6Jamie IV, Bruce DW, Terence JC. HERG K+ channels: friend and foe[J]. TRENDS in Pharmacological Sciences, 2001,22(5):240-246. 被引量：1
7Picard S, Lacroix P. QT interval prolongation and cardiac risk assessment for novel drugs[J]. Curr Opin Investig Drugs, 2003,4(3): 303-308. 被引量：1
